PHILIP ISHERWOOD: Open Payments
NPI 1497781611 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 20 payments from 5 companies in 2025. Trend: 2023 $2,455 · 2024 $436 · 2025 $493
Food & beverage: $493
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 8 | $246 |
| Axsome Therapeutics, Inc. | 5 | $88 |
| Lundbeck LLC | 3 | $74 |
| Braeburn Inc. | 2 | $46 |
| Indivior Inc. | 2 | $39 |
Products named: Auvelity, REXULTI, BRIXADI, SUBLOCADE, Epclusa.
Industry payments across LA — which companies pay providers there.
